TrialBritish journal of clinical pharmacology2015

The FNTB promoter polymorphism rs11623866 as a potential predictive biomarker for lonafarnib treatment of ovarian cancer patients.

Hagen Sjard Bachmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.